Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
m032
Anaplastic Astrocytoma
University of Alabama at Birmingham
P1/2
CC
(45)
m032
Gliosarcoma
University of Alabama at Birmingham
P1/2
CC
(45)
Mb-Dnpm1-Tcr.1
Acute Myeloid Leukemia
Miltenyi Biomedicine GmbH
P1/2
CC
(45)
mbs314
Plasma Cell Myeloma
Beijing Mabworks Biotech Co., Ltd.
P1/2
CC
(45)
mdx2001
Gastroesophageal Cancer
ModeX Therapeutics, An OPKO Health Company
P1/2
CC
(45)
mdx2001
Renal Cell Carcinoma
ModeX Therapeutics, An OPKO Health Company
P1/2
CC
(45)
mdx2001
Thyroid Cancer
ModeX Therapeutics, An OPKO Health Company
P1/2
CC
(45)
mdx2003
Diffuse Large B-Cell Lymphoma
ModeX Therapeutics, An OPKO Health Company
P1/2
CC
(45)
mdx2003
Lymphoplasmacytic Lymphoma
ModeX Therapeutics, An OPKO Health Company
P1/2
CC
(45)
Memory-Like Natural Killer Cells
Childhood Acute Myeloid Leukemia
Washington University School of Medicine
P1/2
CC
(45)
Mesenchymal Stem Cells Derived Exosomes
Pancreatic Adenocarcinoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Meta10-Til
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Mirdametinib
Her2-Receptor Negative Breast Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CC
(45)
mk-1045
Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLC
P1/2
CC
(45)
mk-5684
Metastatic Neoplasm
Merck Sharp & Dohme LLC
P1/2
CC
(45)
mr001 bispecific antibody for
Triple-Negative Breast Carcinoma
Shenzhen Majory Biotechnology Co., Ltd.
P1/2
CC
(45)
Mrna-2808
Plasma Cell Myeloma
ModernaTX, Inc.
P1/2
CC
(45)
Mrt-2359
Small Cell Lung Carcinoma
Monte Rosa Therapeutics, Inc
P1/2
CC
(45)
mt027
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
mt-101
Mycosis Fungoides
Myeloid Therapeutics
P1/2
CC
(45)
mt-4561
Soft Tissue Sarcoma
Tanabe Pharma America, Inc.
P1/2
CC
(45)
Mva-Magea3
Esophageal Squamous Cell Carcinoma
Cancer Research UK
P1/2
CC
(45)
n17350
Head And Neck Neoplasm
Onchilles Pharma Inc
P1/2
CC
(45)
Naxitamab
Breast Cancer
Margaret Gatti-Mays
P1/2
CC
(45)
nb-4746
Amyotrophic Lateral Sclerosis
Nura Bio
P1/2
CC
(45)
Showing 3676 to 3700 of 6,299 assets
Previous
Page 148 of 252
Next